Related Experiment Videos
Survey of the rate of PSA testing in general practice
1Cancer Screening Evaluation Unit, Institute of Cancer Research, Section of Epidemiology, D Block, Cotswold Road, Sutton, Surrey, SM2 5NG, UK.
British Journal of Cancer
|September 5, 2001
Abstract:
The use of prostate specific antigen (PSA) test could have a large impact on the incidence of prostate cancer in the UK. Over a period of 1 year (1999), 3.5% out of 160 015 men aged > 45 on a GP database, who had no previous record of prostate cancer, had a PSA test. Of the tested men, 21.3% had a PSA > 4 ng/ml. Future data need to distinguish between men with and without symptoms.